|
| | Doxorubicin IMpurity B Basic information |
| Product Name: | Doxorubicin IMpurity B | | Synonyms: | (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;Doxorubicin Hydrochloride impurity B;Doxorubicin IMpurity B;(8S,10S)-10-[(3-AMino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-broMo-1,1-diMethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-5,12-naphthacenedione
(Doxorubicin IMpurity);Doxorubicin Impurity 2（Doxorubicin EP Impurity B）;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(2-bromo-1,1-dimethoxyethyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;Doxorubicin EP Impurity B;Doxorubicin Ketal Impurity | | CAS: | 106401-68-7 | | MF: | C29H34BrNO11 | | MW: | 652.48 | | EINECS: | 204-888-2 | | Product Categories: | Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals | | Mol File: | 106401-68-7.mol |  |
| | Doxorubicin IMpurity B Chemical Properties |
| Boiling point | 804.7±65.0 °C(Predicted) | | density | 1.63±0.1 g/cm3(Predicted) | | pka | 7.51±0.60(Predicted) |
| | Doxorubicin IMpurity B Usage And Synthesis |
| Uses | (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione, is the metabolite of Doxorubicin (D558000), which is a neoplasm inhibitor | | Uses | Doxorubicin Ketal Derivative is an impurity and a derivative compound of Doxorubicin. An antibacterial. |
| | Doxorubicin IMpurity B Preparation Products And Raw materials |
|
